---
figid: PMC6287148__GRP2018-9250757.001
figtitle: Mitogen-activated protein kinase pathway
organisms:
- NA
pmcid: PMC6287148
filename: GRP2018-9250757.001.jpg
figlink: /pmc/articles/PMC6287148/figure/fig1/
number: F1
caption: Diagram of the mitogen-activated protein kinase pathway. A signalling epidermal
  growth factor binds to the receptor (EGFR) on the cell surface causing its phosphorylation
  and activation. The activated signal is passed to scaffolding proteins (GRB2 and
  SOS) which in turn promotes the removal of GDP from membrane-bound KRAS. KRAS then
  binds GTP, allowing its activation, and undergoes conformational change to bind
  and phosphorylate BRAF. The signalling cascade continues through MEK and ERK. Activated
  ERK translocates to the nucleus where it recruits transcription factors involved
  in cellular survival and growth. The V600E BRAF mutation allows for constitutive
  activation of BRAF and continuation of downstream signalling regardless of upstream
  regulation.
papertitle: 'How the BRAF V600E Mutation Defines a Distinct Subgroup of Colorectal
  Cancer: Molecular and Clinical Implications.'
reftext: Catherine E. Bond, et al. Gastroenterol Res Pract. 2018;2018:9250757.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8496385
figid_alias: PMC6287148__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6287148__F1
ndex: 8b50ae29-df11-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6287148__GRP2018-9250757.001.html
  '@type': Dataset
  description: Diagram of the mitogen-activated protein kinase pathway. A signalling
    epidermal growth factor binds to the receptor (EGFR) on the cell surface causing
    its phosphorylation and activation. The activated signal is passed to scaffolding
    proteins (GRB2 and SOS) which in turn promotes the removal of GDP from membrane-bound
    KRAS. KRAS then binds GTP, allowing its activation, and undergoes conformational
    change to bind and phosphorylate BRAF. The signalling cascade continues through
    MEK and ERK. Activated ERK translocates to the nucleus where it recruits transcription
    factors involved in cellular survival and growth. The V600E BRAF mutation allows
    for constitutive activation of BRAF and continuation of downstream signalling
    regardless of upstream regulation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - GRB2
  - KRAS
  - NRAS
  - XYLT2
  - SOS1
  - SOS2
  - EGFR
  - BRAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - GDP-GTP
  - Noonan syndrome
---
